Verona Pharma Archives -

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary

Verona cues up filings for COPD drug after it aces phase 3 test

https://pharmaphorum.com/news/verona-cues-up-filings-for-copd-drug-after-it-aces-phase-3-test/

Verona Pharma is starting a pilot study of its inhaled respiratory diseases drug ensifentrine in patients hospitalised with

Verona to test COPD hopeful ensifentrine in COVID-19 patients

https://pharmaphorum.com/news/verona-to-test-copd-hopeful-ensifentrine-in-covid-19-patients/

More than two years after first saying it would take its lead drug into a pivotal trial, Verona

Verona says FDA backs plan to take COPD drug into phase 3

https://pharmaphorum.com/news/verona-says-fda-backs-plan-to-take-copd-drug-into-phase-3/

We speak to Verona Pharma’s CEO Jan-Anders Karlsson to find out how the company is looking to tackle

COPD: the world’s biggest neglected disease?

https://pharmaphorum.com/r-d/views-analysis-r-d/copd-the-worlds-biggest-neglected-disease/

UK biotech hopes RPL554 could be a disease modifying drug.

Verona pushes on with COPD drug after £70m fundraiser

https://pharmaphorum.com/news/verona-copd-ipo/

After a slow first quarter, biotech IPOs may finally start to come into vogue in the coming months

Are biotech IPOs back in fashion?

https://pharmaphorum.com/news/biotech-ipos-coming-back-fashion/

Verona Pharma